Nuremberg, Germany

Dieter Welzel

USPTO Granted Patents = 7 


Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Nürnberg, DE (2006)
  • Nuremberg, DE (1984 - 2020)

Company Filing History:


Years Active: 1984-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovations of Dieter Welzel

Introduction

Dieter Welzel is a notable inventor based in Nuremberg, Germany. He has made significant contributions to the field of medicine, particularly in the development of heparin-based therapies. With a total of seven patents to his name, Welzel's work has had a profound impact on the prevention and treatment of thromboembolic diseases.

Latest Patents

Among his latest patents is the invention of medium molecular weight heparin (MMWH 10.5 kD), which is designed for the prevention and treatment of venous thromboembolism in malignant diseases. Another significant patent involves a process for prophylaxis and therapy of thrombotic processes, which includes preparing heparin with an average molecular weight ranging from 10 to 11.5 kD. This process also involves formulating a pharmaceutical preparation that utilizes this heparin for effective treatment.

Career Highlights

Dieter Welzel has worked with prominent companies in the pharmaceutical industry, including Sandoz GmbH and Vascular Laboratory, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to innovative medical solutions.

Collaborations

Welzel has collaborated with esteemed colleagues such as Hans Buhlmann and Helmut Wolf, further enhancing the quality and reach of his inventions.

Conclusion

Dieter Welzel's contributions to medical science through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the treatment of thromboembolic diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…